Intec Pharma Ltd. (NASDAQ: NTEC) is -42.04% lower on its value in year-to-date trading and has touched a low of $0.13 and a high of $4.36 in the current 52-week trading range. The NTEC stock was last observed hovering at around $0.29 in the recent trading session, with the current loss setting it -0.01%.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
At last check, trading at $0.28, the stock is -15.50% and -4.58% below its SMA20 and SMA50 respectively. However, with a current trading volume of 0.53 million and changing -1.97% at the moment leaves the stock -33.48% off its SMA200. NTEC registered -92.64% loss for a year compared to 6-month loss of -41.69%. The firm has a 50-day simple moving average (SMA 50) of $0.3275 and a 200-day simple moving average (SMA200) of $0.3152.
The stock witnessed a -30.95% gain in the last 1 month and extending the period to 3 months gives it a 54.64%, and is 0.07% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.50% over the week and 10.79% over the month.
Distance from 52-week low is 114.56% and -93.49% from its 52-week high.
Intec Pharma Ltd. (NTEC) Analyst Forecasts
Intec Pharma Ltd. quarterly earnings per share for the current quarter are estimated at -$0.05.The EPS is expected to grow by 83.70% this year.
Intec Pharma Ltd. (NTEC) Top Institutional Holders
32 institutions hold shares in Intec Pharma Ltd. (NTEC), with 7.06M shares held by insiders accounting for 10.19% while institutional investors hold 18.95% of the company’s shares. The shares outstanding are 69.27M, and float is at 56.40M with Short Float at 5.09%. Institutions hold 17.02% of the Float.
The top institutional shareholder in the company is Meitav Dash Investments Ltd with over 2.42 million shares valued at $0.48 million. The investor’s holdings represent 3.49% of the NTEC Shares outstanding. As of Mar 30, 2020, the second largest holder is Adage Capital Partners GP L.L.C. with 1.46 million shares valued at $0.29 million to account for 2.11% of the shares outstanding. The other top investors are Phoenix Holdings Ltd. which holds 0.6 million shares representing 0.87% and valued at over $0.12 million, while AdvisorShares Investments, LLC holds 0.61% of the shares totaling 0.42 million with a market value of $82612.0.
Intec Pharma Ltd. (NTEC) Insider Activity
A total of 2 insider transactions have happened at Intec Pharma Ltd. (NTEC) in the last six months, with sales accounting for 2 and purchases happening 0 times. The most recent transaction is an insider sale by Dexcel Pharma Technologies Ltd, the company’s 10% Owner. SEC filings show that Dexcel Pharma Technologies Ltd sold 110,000 shares of the company’s common stock on Feb 04 at a price of $0.29 per share for a total of $31900.0. Following the sale, the insider now owns 4.23 million shares.
Intec Pharma Ltd. disclosed in a document filed with the SEC on Feb 03 that Dexcel Pharma Technologies Ltd (10% Owner) sold a total of 80,000 shares of the company’s common stock. The trade occurred on Feb 03 and was made at $0.32 per share for $25440.0. Following the transaction, the insider now directly holds 4.34 million shares of the NTEC stock.
Still, SEC filings show that on Jan 31, Dexcel Pharma Technologies Ltd (10% Owner) disposed off 725,951 shares at an average price of $0.31 for $0.22 million. The insider now directly holds 4,424,897 shares of Intec Pharma Ltd. (NTEC).
Intec Pharma Ltd. (NTEC): Who are the competitors?
Omeros Corporation (OMER) is 1.50% up on the 1-year trading charts. Short interest in the company’s stock has risen 90.25% from the last report on May 14, 2020 to stand at a total of 0.28 million short shares sold with a short interest ratio of 0.19.